U.S. Department of Health and Human Services
Clinical Trials Search Results
Search results 1 - 10 of 28 for FDA-Approved Opportunistic Infection and Coinfection Drugs, Peginterferon Alfa-2b
Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)
Condition: HIV; HIV/AIDS; HIV-1 Infection
NCT ID: NCT03588715- Green tick iconRecruiting
- Email this trial
Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children
Condition: HIV Infections
NCT ID: NCT00006325- Red stop iconCompleted
- Globe iconEn español
- Email this trial
Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
Condition: HIV Infections
NCT ID: NCT00005012- Red stop iconCompleted
- Email this trial
Phase III PEG-Intron in HIV-infected Patients (Study P00738)
Condition: HIV Infections; AIDS
NCT ID: NCT00035360- Red stop iconCompleted
- Email this trial
Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
Condition: HIV Infection
NCT ID: NCT01295515- Red stop iconCompleted
- Text file iconHas Results
- Email this trial
Post-marketing Surveillance of HIV-infected Patients With Chronic Hepatitis C Treated With PegIntron Pen and Rebetol (Study P04584)
Condition: Chronic Hepatitis C; Hepatitis C; HIV Infections
NCT ID: NCT00736242- Red stop iconCompleted
- Text file iconHas Results
- Email this trial
Peginterferon Alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients
Condition: Hepatitis C; HIV Infections
NCT ID: NCT00018031- Red stop iconCompleted
- Text file iconHas Results
- Email this trial
Pilot Peg-Interferon-a2b in Decreasing Viral DNA in HIV
Condition: HIV-1 Infection
NCT ID: NCT01935089- Question Mark iconUnknown status
- Email this trial
Efficacy and Safety of PegIntron Plus Ribavirin for Treatment of Chronic Hepatitis C in HIV-Infected Subjects (Study P04469)(TERMINATED)
Condition: Hepatitis C, Chronic; Hepacivirus; HIV Infections
NCT ID: NCT00687544- Red stop iconTerminated
- Text file iconHas Results
- Email this trial
Reducing Proviral HIV DNA With Interferon-a
Condition: HIV; HIV/AIDS
NCT ID: NCT02227277- Question Mark iconUnknown status
- Email this trial
Email Updates
